Filter
706
Filtered Results: 706
Text search:
FDA
Featured
Recommendations
93
New Publications
138
Language
Document type
No document type
338
Guidelines
190
Studies & Reports
91
Manuals
27
Fact sheets
25
Strategic & Response Plan
16
Training Material
9
Resource Platforms
3
Infographics
3
Brochures
2
Situation Updates
2
Countries / Regions
India
40
Latin America and the Carribbean
21
Ghana
20
Russia
17
Philippines
15
Global
13
Germany
12
Brazil
12
Myanmar / Burma
12
Congo, Democratic Republic of
11
South Africa
10
Middle East and North Africa
9
Kenya
8
West and Central Africa
8
Syria
7
Nigeria
7
USA
7
Argentina
7
Ecuador
7
Colombia
6
Ukraine
6
Senegal
6
Western and Central Europe
6
Uganda
6
Yemen
6
Angola
6
Sierra Leone
5
Mozambique
5
Paraguay
5
Eastern Europe
5
Ethiopia
5
South Sudan
5
Indonesia
5
Nepal
4
Thailand
4
Burkina Faso
4
Peru
4
Eastern Europe and Central Asia
4
France
4
East and Southern Africa
4
Sudan
4
Mali
4
Liberia
4
Benin
3
Rwanda
3
Chile
3
Guinea
3
Africa
3
Venezuela
3
Tanzania
3
South–East Asia Region
3
Spain
3
Bolivia
3
Bangladesh
3
Tajikistan
2
El Salvador
2
Albania
2
Niger
2
Haiti
2
Asia
2
Guinea-Bissau
2
Jordan
2
Saudi Arabia
2
Portugal
2
Côte d’Ivoire / Ivory Coast
2
Vietnam
2
Namibia
2
Iraq
2
Mexico
1
Turkey
1
Kazakhstan
1
Cameroon
1
Singapore
1
Congo-Brazzaville
1
Malawi
1
Zimbabwe
1
Morocco
1
Qatar
1
Mauritania
1
Armenia
1
Cambodia
1
Dominican Republic
1
Tunisia
1
United Kingdom
1
Belarus
1
Israel
1
Lebanon
1
Nicaragua
1
Moldova
1
Egypt
1
Honduras
1
Chad
1
Libya
1
Botswana
1
Somalia
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
228
Clinical Guidelines
85
Pharmacy & Technologies
23
Women & Child Health
20
Public Health
14
Key Resources
12
Capacity Building
5
Toolboxes
COVID-19
159
Mental Health
69
TB
63
HIV
53
Pharmacy
39
AMR
36
Ebola & Marburg
31
Rapid Response
20
NTDs
14
Specific Hazards
13
Planetary Health
10
NCDs
10
Zika
9
Refugee
7
Cholera
5
Natural Hazards
4
Caregiver
4
Conflict
3
Global Health Education
3
Health Financing Toolbox
2
Disability
1
Includes a Special Report on the Financial and Personal Benefits of Early Diagnosis
2018 Alzheimer’s Disease Facts and Figures is a statistical resource for U.S. data related to Alzheimer’s disease,
the most common cause of dementia. Background and context for interpretating the data are con...
Technology landscape
Afr J Thoracic Crit Care Med 2021;27(4):Published online 22 October 2021. https://doi.org/10.7196/AJTCCM.2021.v27i4.173
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
Anxiety disorders
Chapter F.2
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Traitements contre la maladie à virus Ebola
recommended
Cette première version des orientations evolutives relatives a la prise en charge clinique de la MVE contient quatre nouvelles recommandations concernant l’utilisation de traitements contre la MVE, y compris deux recommandations fortes en faveur de l’utilisation de thérapies à base d’antico...
The Ghanaian Cabinet approved the antimicrobial resistance (AMR)Policy and Implementation plan(hereafter referred to as the national action plan or NAP)in December 2017, whilst the country case study was in progress. This has set in motion the implementation phase for Ghana, which is a long awaited...
Mood disorders
Chapter E.1
2015 edition
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
Troubles Anxieux
Chapitre F.3
Edition en français
Traduction : Alexis Revet
Sous la direction de : Jean-Philippe Raynaud Avec le soutien de la SFPEADA
Diese Faktenboxen sollen Ihnen helfen, Nutzen und Schaden einer Schutzimpfung gegen COVID-19 abzuwägen. Die Informationen und Zahlen stellen keine endgültige Bewertung dar. Sie basieren auf den derzeit besten wissenschaftlichen Erkenntnissen.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases...
16.7.2021
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
